Vaccination against human papillomavirus – an impact on preterm delivery? Estimations based on literature review

References

• Wright TC, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003; 189: 295–304
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. Lower Genital Tract Neoplasia: study group recommendations 2003. Available from: URL: http://www.rcog.org.uk/mainpages.asp?PageID=1146 (accessed Feb 2006).
   Google Scholar
• Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000: CD001318.
   Google Scholar
• Sjoborg KD, Vistad I, Myhr SS, Svenningsen R, Herzog C, Kloster-Jensen A, et al. Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstet Gynecol Scand. 2007; 86: 423–8
   PubMed Web of Science ®Google Scholar
• Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol. 2003; 102: 1058–62
   PubMed Web of Science ®Google Scholar
• Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489–98
   PubMed Web of Science ®Google Scholar
• Nohr B, Tabor A, Frederiksen K, Kjaer SK. Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery. Acta Obstet Gynecol Scand. 2007; 86: 596–603
   PubMed Web of Science ®Google Scholar
• Jakobsson M, Gissler M, Sainio S, Paavonen J, Tapper AM. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2007; 109: 309–13
   PubMed Web of Science ®Google Scholar
• Bruinsma F, Lumley J, Tan J, Quinn M. Precancerous changes in the cervix and risk of subsequent preterm birth. BJOG 2007; 114: 70–80
   PubMed Web of Science ®Google Scholar
• El-Bastawissi AY, Becker TM, Daling JR. Effect of cervical carcinoma in situ and its management on pregnancy outcome. Obstet Gynecol. 1999; 93: 207–12
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC) . Cervix cancer screening. Handbook of cancer prevention, Vol. 10. Lyon: IARC Press, 2005.
   Google Scholar
• National Health Service . Cervical Screening Programme, England: 2004–2005. Leeds: Health and Social Care Information Service; 2005. Report No.: Statistical Bulletin 2005/09/HSCIC.
   Google Scholar
• The Cancer Registry of Norway . Cancer in Norway 2005. Oslo, 2007.
   Google Scholar
• zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000; 92: 690–8
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Meijer CJ. Do HPV-negative cervical carcinomas exist?. J Pathol. 1997; 181: 253–4
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518–27
   PubMed Web of Science ®Google Scholar
• Koutsky LA, Harper DM. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine 2006; 24: 114–21
   Web of Science ®Google Scholar
• FUTURE II Study Group . Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915–27.
   PubMed Web of Science ®Google Scholar
• Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367: 1247–55
   PubMed Web of Science ®Google Scholar
• Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369: 2161–70
   PubMed Web of Science ®Google Scholar
• Platt MJ, Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et al. Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 2007; 369: 43–50
   PubMed Web of Science ®Google Scholar
• Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol. 2004; 104: 78–87
   PubMed Web of Science ®Google Scholar
• Yu VY. Global, regional and national perinatal and neonatal mortality. J Perinat Med. 2003; 31: 376–9
   PubMed Web of Science ®Google Scholar
• Richardus JH Graafmans WC Verloove-Vanhorick SP Mackenbach JP EuroNatal International Audit Panel, EuroNatal Working Group . Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit. BJOG 2003; 110:97–105.
   PubMed Web of Science ®Google Scholar
• Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002; 360: 1489–97
   PubMed Web of Science ®Google Scholar
• The Pathology Data Bank of Denmark; 2007. Available at: http://www.patobank.dk/ (accessed Sep 2007).
   Google Scholar
• Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998; 45: 320–3
   PubMed Web of Science ®Google Scholar
• Eurostat . European Commision. Study of low fertility in the regions of the European Union: places periods and causes. Populations and Social Conditions 3/2004/F/no 4.
   Google Scholar
• Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Munoz J, et al. HPV and cervical cancer in the world 2007 report. Vaccine 2007; 25: C1–230
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Assessment report for Gardasil. European Medicines Agency, London 2008. Available online at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/gardasil/EMEA-H-703-II-06-AR.pdf (accessed Jul 2008).
   Google Scholar
• WHO vaccine-preventable disease: monitoring system. 2006 global summary. Available at: http://www.who.int/vaccines-documents/GlobalSummary/GlobalSummary (accessed Aug 2006).
   Google Scholar
• Sysvak dekningsstatistikk. Available at: http://www.fhi.no/tema/vaksine/dekning/ (accessed Nov 2007).
   Google Scholar
• Lund E, Bjerkedal T. Cancer in situ of the uterine cervix. Increased perinatal death and prematurity after conization. J Nor Med Assoc. 1986; 106: 543–6
   Google Scholar
• Kristensen J, Langhoff-Roos J, Wittrup M, Bock JE. Cervical conization and preterm delivery/low birth weight. A systematic review of the literature. Acta Obstet Gynecol Scand. 1993; 72: 640–4
   PubMed Web of Science ®Google Scholar
• World Health Organization . WHO Office of information. WHO Features 1990; 152:1–6.
   Google Scholar
• Simms I, Fairly C. Epidemiology of genital warts in England and Wales: 1971–1994. Genitourin Med. 1997; 73: 365–7
   PubMedGoogle Scholar
• Wallace LA, Young D, Brown A, Cameron JC, Ahmed S, Duff R, et al. Costs of running a universal adolescent hepatitis B vaccination programme. Vaccine 2005; 23: 5624–1
   PubMed Web of Science ®Google Scholar